Literature DB >> 26440590

Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome.

Juan Wang1,2, Huiyong Peng1, Jie Tian3, Jie Ma2, Xinyi Tang1, Ke Rui2, Xinyu Tian2, Yungang Wang2, Jianguo Chen1, Liwei Lu4, Huaxi Xu2, Shengjun Wang5,6.   

Abstract

Long noncoding RNAs (lncRNA) play key roles in regulating autoimmunity and immunity balance. LncRNA TMEVPG1, which is encoded by a gene located near the Ifn gene, contributes to interferon gamma expression. We investigated the expression of TMEVPG1 in patients with Sjögren syndrome (SS) to determine its role in the pathogenesis of SS. In this study, we detected the relative expression of TMEVPG1 in CD4(+) T cells of 25 SS patients and 25 healthy donors. Moreover, the proportion of Th1 cells and T-bet levels was also analyzed. Furthermore, we explored the correlation between the expression of TMEVPG1 and the level of autoantibodies, erythrocyte sedimentation rate (ESR) and IgG in SS patients. Our results indicated that the proportion of Th1 cells and the levels of TMEVPG1 and T-bet were increased in SS patients. In addition, the level of expression of TMEVPG1 was correlated with the level of SSA, ESR and IgG. Our data suggest that upregulation of lncRNA TMEVPG1 may be involved in the pathogenesis of Sjögren syndrome.

Entities:  

Keywords:  Long noncoding RNA; Sjögren syndrome; T helper type 1 cells; TMEVPG1

Mesh:

Substances:

Year:  2016        PMID: 26440590     DOI: 10.1007/s12026-015-8715-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  35 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome.

Authors:  Gabriela Hernández-Molina; Gustavo Leal-Alegre; Martha Michel-Peregrina
Journal:  Autoimmun Rev       Date:  2010-09-15       Impact factor: 9.754

3.  MiR-346 regulates CD4⁺CXCR5⁺ T cells in the pathogenesis of Graves' disease.

Authors:  Juan Chen; Jie Tian; Xinyi Tang; Ke Rui; Jie Ma; Chaoming Mao; Yingzhao Liu; Liwei Lu; Huaxi Xu; Shengjun Wang
Journal:  Endocrine       Date:  2015-02-11       Impact factor: 3.633

4.  Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage.

Authors:  Diana C Spierings; Daniel McGoldrick; Ann Marie Hamilton-Easton; Geoffrey Neale; Elizabeth P Murchison; Greg J Hannon; Douglas R Green; Sebo Withoff
Journal:  Blood       Date:  2011-03-14       Impact factor: 22.113

5.  Th17 cells play a critical role in the development of experimental Sjögren's syndrome.

Authors:  Xiang Lin; Ke Rui; Jun Deng; Jie Tian; Xiaohui Wang; Shengjun Wang; King-Hung Ko; Zhijun Jiao; Vera Sau-Fong Chan; Chak Sing Lau; Xuetao Cao; Liwei Lu
Journal:  Ann Rheum Dis       Date:  2014-02-26       Impact factor: 19.103

6.  Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells.

Authors:  Takeshi Chiyomaru; Shinichiro Fukuhara; Sharanjot Saini; Shahana Majid; Guoren Deng; Varahram Shahryari; Inik Chang; Yuichiro Tanaka; Hideki Enokida; Masayuki Nakagawa; Rajvir Dahiya; Soichiro Yamamura
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

7.  Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.

Authors:  Noriyoshi Ogawa; Li Ping; Li Zhenjun; Yukiko Takada; Susumu Sugai
Journal:  Arthritis Rheum       Date:  2002-10

8.  Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity.

Authors:  Kaleb M Pauley; Carol M Stewart; Adrienne E Gauna; Lauren C Dupre; Riya Kuklani; Annie L Chan; Brad A Pauley; Westley H Reeves; Edward K L Chan; Seunghee Cha
Journal:  Eur J Immunol       Date:  2011-05-27       Impact factor: 5.532

9.  A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.

Authors:  S Cha; J Brayer; J Gao; V Brown; S Killedar; U Yasunari; A B Peck
Journal:  Scand J Immunol       Date:  2004-12       Impact factor: 3.487

10.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals.

Authors:  Mitchell Guttman; Ido Amit; Manuel Garber; Courtney French; Michael F Lin; David Feldser; Maite Huarte; Or Zuk; Bryce W Carey; John P Cassady; Moran N Cabili; Rudolf Jaenisch; Tarjei S Mikkelsen; Tyler Jacks; Nir Hacohen; Bradley E Bernstein; Manolis Kellis; Aviv Regev; John L Rinn; Eric S Lander
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

View more
  25 in total

Review 1.  Cytokines and Long Noncoding RNAs.

Authors:  Susan Carpenter; Katherine A Fitzgerald
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2.  A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation.

Authors:  David Padua; Swapna Mahurkar-Joshi; Ivy Ka Man Law; Christos Polytarchou; John P Vu; Joseph R Pisegna; David Shih; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-04       Impact factor: 4.052

3.  IFNG/IFNG-AS1 expression level balance: implications for autism spectrum disorder.

Authors:  Hamid Fallah; Arezou Sayad; Fatemeh Ranjbaran; Fatemeh Talebian; Soudeh Ghafouri-Fard; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2019-11-14       Impact factor: 3.584

Review 4.  Expanding Roles of Noncoding RNAs in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Yiwei Shen; Bo Qu; Nan Shen
Journal:  Curr Rheumatol Rep       Date:  2022-03-03       Impact factor: 4.592

Review 5.  Long non-coding RNAs in rheumatoid arthritis.

Authors:  Zheng Li; Xingye Li; Chao Jiang; Wenwei Qian; Gary Tse; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2017-11-07       Impact factor: 6.831

Review 6.  LncRNAs in adaptive immunity: role in physiological and pathological conditions.

Authors:  Pedro Faria Zeni; Marek Mraz
Journal:  RNA Biol       Date:  2020-11-09       Impact factor: 4.652

7.  IL-17A weakens the antitumor immuity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice.

Authors:  Juan Wang; Yue Zhang; Kai Yin; Peiqi Xu; Jie Tian; Jie Ma; Xinyu Tian; Yungang Wang; Xinyi Tang; Huaxi Xu; Shengjun Wang
Journal:  Oncotarget       Date:  2017-01-17

8.  Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer.

Authors:  Xinyu Tian; Jie Ma; Ting Wang; Jie Tian; Yue Zhang; Lingxiang Mao; Huaxi Xu; Shengjun Wang
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

9.  Differential long non-coding RNA expression profile and function analysis in primary Sjogren's syndrome.

Authors:  Xiaochan Chen; Qi Cheng; Yan Du; Lei Liu; Huaxiang Wu
Journal:  BMC Immunol       Date:  2021-07-20       Impact factor: 3.615

10.  The Long Noncoding RNA IFNG-AS1 Promotes T Helper Type 1 Cells Response in Patients with Hashimoto's Thyroiditis.

Authors:  Huiyong Peng; Yingzhao Liu; Jie Tian; Jie Ma; Xinyi Tang; Ke Rui; Xinyu Tian; Chaoming Mao; Liwei Lu; Huaxi Xu; Pengcheng Jiang; Shengjun Wang
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.